Zobrazeno 1 - 10
of 486
pro vyhledávání: '"Patrice Chevallier"'
Autor:
Patrice Chevallier, Cristina Castilla-Llorente, Anne Thiebaut-Bertand, Stéphanie Nguyen, Maud D'Aveni, Rabah Redjoul, Mathieu Leclerc, Magalie Joris, Alexis Maillard, Hélène Labussière-Wallet, Carmen Botella-Garcia, Michael Loschi, Marion Klemencie, Sylvain Chantepie, Ana Berceanu, Amandine Le Bourgeois, Sylvie François, Anne Huynh, Tony Marchand
Publikováno v:
Blood
Blood, 2022, 139 (1), pp.134-137. ⟨10.1182/blood.2021014232⟩
Blood, 2022, 139 (1), pp.134-137. ⟨10.1182/blood.2021014232⟩
International audience; Three reports address the protection of the vulnerable population of patients with hematologic malignancies in the face of the ongoing COVID pandemic. The reports suggest that some patients who fail to mount a B-cell response
Publikováno v:
Journal of Infection
Journal of Infection, WB Saunders, 2021, ⟨10.1016/j.jinf.2021.07.027⟩
Journal of Infection, WB Saunders, 2021, ⟨10.1016/j.jinf.2021.07.027⟩
International audience
Publikováno v:
World Journal of Gastroenterology. 27:7792-7800
Gut microbiome in allogeneic hematopoietic stem cell transplantation and specific changes associated with acute graft vs host disease
Autor:
Maria Elkababri, Tereza Coman, Cécile Pochon, Quentin Cabrera, Asmaa Quessar, Mhamed Harif, Faty Hamzy, Mohamed Amine Bekadja, Patrice Chevallier, Amal Laamiri, Ibrahim Yakoub-Agha, Nabil Yafour
Publikováno v:
Bulletin du Cancer. 108:S10-S19
Hematopoietic cell transplantation (HCT) is the curative treatment for many malignant and non-malignant blood disorders and some solid cancers. However, transplant procedures are considered tertiary level care requiring a high degree of technicality
Autor:
Hélène Labussière-Wallet, Annalisa Ruggeri, Edouard Forcade, Jorge Sierra, Myriam Labopin, Deborah Desmier, Frédéric Baron, Nathalie Fegueux, Mohamad Mohty, Didier Blaise, Jan J. Cornelissen, Thomas Cluzeau, Jennifer Byrne, Patrice Chevallier, Arnon Nagler
Publikováno v:
Bone Marrow Transplantation, 57(10), 1514-1519. Nature Publishing Group
BONE MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
BONE MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Background: Achieving a first complete remission (CR1) is an important prognostic factor for transplantation outcome. However, there are no data in the setting of cord blood transplantation (CBT) indicating whether the number of induction courses (1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42b43127bd8f90af1b23e872a8f8b654
https://pure.eur.nl/en/publications/f3bb2668-f6e4-4fd5-8761-91d9f0537507
https://pure.eur.nl/en/publications/f3bb2668-f6e4-4fd5-8761-91d9f0537507
Autor:
Mark A. Schroeder, Steven M. Devine, Yi-Bin Chen, Andrejus Parfionovas, Yngvar Fløisand, Syed Quadri, Dominik Selleslag, Chunlin Chen, Ibrahim Yakoub-Agha, Patrice Chevallier, Mona Akbari, Mohamad Mohty, Johan Jansson, Anne S. Renteria
Publikováno v:
Bone Marrow Transplantation
Bone Marrow Transplantation, In press, ⟨10.1038/s41409-021-01356-0⟩
Bone Marrow Transplantation, Nature Publishing Group, In press, ⟨10.1038/s41409-021-01356-0⟩
Bone Marrow Transplantation, In press, ⟨10.1038/s41409-021-01356-0⟩
Bone Marrow Transplantation, Nature Publishing Group, In press, ⟨10.1038/s41409-021-01356-0⟩
Steroid-refractory (SR) acute graft-versus-host disease (aGvHD) remains a significant complication after allogeneic hematopoietic cell transplantation. Systemic corticosteroids are first-line therapy for aGvHD, but apart from ruxolitinib, there are n
Autor:
Xavier Thomas, Lilia Boucinha, Christian Recher, Anne-Sophie Michallet, Sophie Ducastelle-Lepretre, Mauricette Michallet, Stéphanie Nguyen, Clément Rocher, Pierre Peterlin, Etienne Paubelle, Florent Malard, Suzanne Tavitian, Colombe Saillard, Marie-Virginie Larcher, Sarah Bertoli, Evelyne D'incan-Corda, Ollivier Legrand, Patrice Chevallier, Emilie Plantamura, Joël Doré, Anne Vekhoff, Simona Lapusan, Jerome Rey, Lila Gilis, Mohamad Mohty, Cyrielle Gasc, Françoise Isnard
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-11 (2021)
Nature Communications
Nature Communications, Nature Publishing Group, 2021, 12 (1), pp.3084. ⟨10.1038/s41467-021-23376-6⟩
Nature Communications, 2021, 12 (1), pp.3084. ⟨10.1038/s41467-021-23376-6⟩
Nature Communications
Nature Communications, Nature Publishing Group, 2021, 12 (1), pp.3084. ⟨10.1038/s41467-021-23376-6⟩
Nature Communications, 2021, 12 (1), pp.3084. ⟨10.1038/s41467-021-23376-6⟩
Acute myeloid leukemia (AML) intensive chemotherapy combined with broad-spectrum antibiotics, leads to gut microbiota dysbiosis promoting pathological conditions and an increased incidence of complications. Here we report findings from a phase II sin
Autor:
Matthias Edinger, Arnold Ganser, Annalisa Ruggeri, Martin Gramatzki, Arnon Nagler, Myriam Labopin, Patrice Chevallier, Nicolaus Kröger, Eolia Brissot, Didier Blaise, Bipin N. Savani, Fabio Ciceri, Jürgen Finke, Mohamed A. Kharfan-Dabaja, Jaime Sanz, Matthias Stelljes, Eric Deconinck, Mohamad Mohty
Publikováno v:
BRITISH JOURNAL OF HAEMATOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
British Journal of Haematology
British Journal of Haematology, 2021, 193 (3), pp.592-601. ⟨10.1111/bjh.17426⟩
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
British Journal of Haematology
British Journal of Haematology, 2021, 193 (3), pp.592-601. ⟨10.1111/bjh.17426⟩
Optimal donor choice for a second allogeneic haematopoietic cell transplant (allo-HCT) in relapsed acute myeloid leukaemia (AML) remains unknown. We compared overall survival (OS) using registry data from the Acute Leukemia Working Party (ALWP) of th
Autor:
John A. Snowden, Nicole M. A. Blijlevens, Gloria Tridello, Liesbeth C. de Wreede, Jean-Yves Cahn, Eric Deconinck, Johan Maertens, William Arcese, Malgorzata Mikulska, Jan Styczyński, Patrice Chevallier, Murray Martin, Jan J. Cornelissen, Didier Blaise, Nina Knelange, Rafael de la Cámara, Mahmoud Aljurf, Margherita Mauro, Tsila Zuckerman, Aliénor Xhaard, Noel Milpied, Diana Averbuch, Tobias Gedde-Dahl, Jennifer Byrne, Simone Cesaro, Bruno Lioure, Eefke Petersen, Per Ljungman, Ram Malladi
Publikováno v:
Bone Marrow Transplantation, 56(7), 1563-1572. SPRINGERNATURE
Bone Marrow Transplantation, 56, 7, pp. 1563-1572
Bone Marrow Transplantation, 56, 1563-1572
Bone Marrow Transplantation, 56, 7, pp. 1563-1572
Bone Marrow Transplantation, 56, 1563-1572
Item does not contain fulltext We assessed the incidence and outcome of early candidemia after hematopoietic stem cell transplant (HSCT). The analysis included all first HSCTs performed from 2000 to 2015 in adult and pediatric patients with a non-leu
Autor:
Johan Maertens, Hélène Labussière-Wallet, Yener Koc, Mohamad Mohty, Giorgia Battipaglia, Didier Blaise, Myriam Labopin, Fabio Ciceri, Anne Huynh, Armin Gerbitz, Hakan Ozdogu, Franciane Paul, Eolia Brissot, Ali Bazarbachi, Rose-Marie Hamladji, Mahmoud Aljurf, Jan J. Cornelissen, Bipin N. Savani, Arnon Nagler, Ellen Meijer, Patrice Chevallier, Annalisa Ruggeri, Boris V. Afanasyev, Gérard Socié
Publikováno v:
Cancer
Cancer, 2021, 127 (2), pp.209-218. ⟨10.1002/cncr.33255⟩
Cancer, Wiley, 2021, 127 (2), pp.209-218. ⟨10.1002/cncr.33255⟩
Battipaglia, G, Labopin, M, Hamladji, R-M, Blaise, D, Chevallier, P, Brissot, E, Gerbitz, A, Socié, G, Afanasyev, B, Ciceri, F, Meijer, E, Koc, Y, Cornelissen, J J, Huynh, A, Ozdogu, H, Maertens, J, Paul, F, Labussière-Wallet, H L, Ruggeri, A, Aljurf, M, Bazarbachi, A, Savani, B, Nagler, A & Mohty, M 2021, ' Post-transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation ', Cancer, vol. 127, no. 2, pp. 209-218 . https://doi.org/10.1002/cncr.33255
Cancer, 127(2), 209-218. John Wiley and Sons Inc.
Cancer, 127(2), 209-218. John Wiley & Sons Inc.
Cancer, 2021, 127 (2), pp.209-218. ⟨10.1002/cncr.33255⟩
Cancer, Wiley, 2021, 127 (2), pp.209-218. ⟨10.1002/cncr.33255⟩
Battipaglia, G, Labopin, M, Hamladji, R-M, Blaise, D, Chevallier, P, Brissot, E, Gerbitz, A, Socié, G, Afanasyev, B, Ciceri, F, Meijer, E, Koc, Y, Cornelissen, J J, Huynh, A, Ozdogu, H, Maertens, J, Paul, F, Labussière-Wallet, H L, Ruggeri, A, Aljurf, M, Bazarbachi, A, Savani, B, Nagler, A & Mohty, M 2021, ' Post-transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation ', Cancer, vol. 127, no. 2, pp. 209-218 . https://doi.org/10.1002/cncr.33255
Cancer, 127(2), 209-218. John Wiley and Sons Inc.
Cancer, 127(2), 209-218. John Wiley & Sons Inc.
International audience; Background: Graft-versus-host disease (GVHD) is a major complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Addition of antithymocyte globulin (ATG) or post-transplantation cyclophosphamide (PTCY